Clinical Trial Update: Cardiovascular Effects of GLP-1 Receptor Activation [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating cardiovascular effects of GLP-1 receptor activation in obesity and prediabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Prediabetes

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Obesity, PreDiabetes | Phase 4 | Status: COMPLETED | Results posted: 2022-08-16